L26/P-513 Association between per- and poly-fluoroalkyl substances with recurrent implantation failure
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Y. Yan.
Abstract (Originalsprache)
Study question Do per- and polyfluoroalkyl substances (PFAS) have associations with recurrent implantation failure (RIF)? Summary answer Perfluorooctanoic acid (PFOA), perfluorobutanoic acid (PFBA), perfluorononanoic acid (PFNA), perfluorohexanoic acid (PFHxA), perfluoropentanoic acid (PFPeA), and hexafluoropropylene oxide dimer acid (HDPO-DA) showed correlation with RIF. What is known already PFAS exposure is widespread and has been proven to adversely affect reproductive health. Previous studies proved the association between PFAS and diseases affecting female reproductive health including premature ovarian insufficiency (POI), polycystic ovary syndrome (PCOS), endometriosis and reproductive cancers. However, to our knowledge, no study has associated PFAS with RIF, a challenging issue which imposes significant financial and psychological burdens on patients. Study design, size, duration A case-control study, including 166 women was conducted between January 2024 and December 2024. 37 of the participants were diagnosed of RIF, and the rest 129 patients were control group. Participants/materials, setting, methods Twenty-five types of PFAS and basal concentrations of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), and anti-Mullerian hormone (AMH) in plasma samples were measured during Days 2–5 of natural menstrual cycle. Adjusted logistic regression and Bayesian kernel machine regression (BKMR) were used to evaluate associations between PFAS and RIF. Main results and the role of chance The concentrations of PFBA, PFHxA, PFPeA, and HFPO-DA in the RIF group were significantly higher than in the control group. We found positive associations between plasma concentrations of PFOA, PFBA, PFNA, PFHxA, PFPeA, and HDPO-DA with the risk of RIF [ORadj=2.363 (95%CI: 1.081- 5.164), 2.730 (95%CI: 1.849 - 4.032), 2.112 (95%CI: 1.177 – 3.790), 4.333 (95%CI: 2.430 - 7.726), 3.302 (95%CI: 2.110 – 5.169), 2.533 (95%CI: 1.411-4.545) respectively, per 2.7-fold increase in plasma concentrations]; while negative association of 6:2 FTS with RIF [ORadj=0.550 (95%CI: 0.354 - 0.853) per 2.7-fold increase in concentrations]. After controlling for other covariates, PFBA and PFHxA were the major contributors based on the BKMR models. Limitations, reasons for caution PFAS concentrations in endometrial tissues were not measured, which restricts our capacity to examine direct associations between PFAS exposure and RIF risk. Finally, the underlying biological mechanisms remain unclear, and in vivo experiments need to be conducted in animal models. Wider implications of the findings Our study is the first to investigate the relationship between PFAS and RIF, and report that PFOA, PFBA, PFNA, PFHxA, PFPeA, and HDPO-DA are positively associated with the risk of RIF. Our findings underscore the potential reproductive risks of PFAS exposure and indicate that reproductive toxicity urgently warrants greater attention. Trial registration number No
Zitieren
APA
Yan, Y. (2026). L26/P-513 Association between per- and poly-fluoroalkyl substances with recurrent implantation failure. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.846
Vancouver
Yan Y. L26/P-513 Association between per- and poly-fluoroalkyl substances with recurrent implantation failure. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.846
BibTeX
@article{Yan2026,
author = {Yan, Y.},
title = {L26/P-513 Association between per- and poly-fluoroalkyl substances with recurrent implantation failure},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.846}
}
EUVIMED